Loading clinical trials...
Loading clinical trials...
The management of patients with SARS-CoV2 in respiratory distress can expose to corneal or retinal lesions induced by the stay in intensive care. Examination by ophthalmologists would make it possible to detect the most of the ophthalmologic problems known in intensive care and to provide an early, preventive or curative therapeutic response when possible, in order to avoid irreversible visual loss. The object of the research is to assess the presence and the importance of surface ophthalmologic lesions, the presence and the importance of retinal or optic nerve lesions, in order to improve the monitoring and primary prevention of this population
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Fondation Adolphe de Rothschild
Paris, France
Start Date
April 27, 2020
Primary Completion Date
July 29, 2020
Completion Date
July 29, 2020
Last Updated
January 6, 2026
23
ACTUAL participants
Ophthalmologic exam
PROCEDURE
Lead Sponsor
Fondation Ophtalmologique Adolphe de Rothschild
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06355232